Cho Kyu Hee, Lee Yeon Ju, Eoh Kyung Jin, Lee Yong Jae, Lee Jung-Yun, Nam Eun Ji, Kim Sunghoon, Kim Young Tae, Kim Sang Wun
Department of Obstetrics and Gynecology, Women's Cancer Center, Yonsei Cancer Center and Institute of Women's Life Medical Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Department of Obstetrics and Gynecology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Obstet Gynecol Sci. 2021 Jan;64(1):90-98. doi: 10.5468/ogs.20216. Epub 2020 Dec 7.
s The aims of this study were to assess the feasibility of single-port laparoscopic surgical staging (SPLS) in early ovarian cancer and to compare the surgical outcomes of SPLS with those of staging laparotomy.
Between January 2014 and December 2018, 40 patients underwent SPLS and 41 patients underwent staging laparotomy at Yonsei Cancer Center. The patients were diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage I ovarian cancer. Variables such as patient age, body mass index (BMI), tumor size, FIGO stage, and perioperative surgical outcomes and survival outcomes of SPLS and laparotomy were compared.
The total operation time was similar between the 2 groups (SPLS: 201.4 vs. laparotomy: 203.0 minutes, P=0.806). The median tumor diameters in the SPLS and laparotomy groups were 11.0 (2.5-28 cm) and 15.4 (6-40 cm), respectively (P=0.001). The SPLS group had lower tumor spillage rate (5.0% vs. 19.5%, P=0.047), less intraoperative blood loss (102.0 vs. 371.5 mL, P<0.001), less postoperative pain, and shorter postoperative hospital stay (5 vs. 9.5 days, P<0.001). The intraoperative major complication rate was similar between groups (2.5% vs. 4.9%, P=0.571). There was no significant difference in progression-free survival between the 2 groups (P=0.945). There were no deaths in either group.
SPLS is feasible in early ovarian cancer and has better perioperative surgical outcomes, in some aspects, than staging laparotomy without compromising survival outcomes. SPLS could be performed in patients suspected to have early ovarian cancer.
本研究旨在评估单孔腹腔镜手术分期(SPLS)在早期卵巢癌中的可行性,并比较SPLS与分期剖腹手术的手术效果。
2014年1月至2018年12月期间,40例患者在延世癌症中心接受了SPLS,41例患者接受了分期剖腹手术。这些患者被诊断为国际妇产科联盟(FIGO)I期卵巢癌。比较了患者年龄、体重指数(BMI)、肿瘤大小、FIGO分期等变量,以及SPLS和剖腹手术的围手术期手术效果和生存结果。
两组的总手术时间相似(SPLS:201.4分钟 vs. 剖腹手术:203.0分钟,P = 0.806)。SPLS组和剖腹手术组的肿瘤中位直径分别为11.0(2.5 - 28 cm)和15.4(6 - 40 cm)(P = 0.001)。SPLS组的肿瘤播散率较低(5.0% vs. 19.5%,P = 0.047),术中失血量较少(102.0 mL vs. 371.5 mL,P < 0.001),术后疼痛较轻,术后住院时间较短(5天 vs. 9.5天,P < 0.001)。两组术中主要并发症发生率相似(2.5% vs. 4.9%,P = 0.571)。两组的无进展生存期无显著差异(P = 0.945)。两组均无死亡病例。
SPLS在早期卵巢癌中是可行的,并且在某些方面比分期剖腹手术具有更好的围手术期手术效果,同时不影响生存结果。对于疑似早期卵巢癌的患者可以进行SPLS。